Survival of the Fittest (to print)

Science publishing is locked in an evolutionary arms race as it edges further into the digital age.

Written byMary Beth Aberlin
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

What’s black and white and ‘read’ all over?” “A blushing zebra!” we’d always shout as kids, even when we knew the right answer: “a newspaper.”

But in the years since I first heard this punning riddle, the rise of the Internet has put a new face on the dissemination of information, challenging both researchers and publishers to find the best way to communicate scientific findings swiftly, cheaply, and effectively. No longer is there a black-and-white way of publishing scientific papers, especially those intended to be read all over.

Novel publishing platforms are being developed and launched at dizzying rates. As we go to press, and within less than a week of each other, both BioMed Central and F1000 announced the launch of new open-access (OA) journals. (The two companies are the brainchildren of Vitek Tracz, former owner of The Scientist.) One of the pioneers of open-access publishing, BioMed Central (now ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies